While longer wear-time is a key market goal, it creates a development bottleneck. A clinical trial for a 30-day device inherently takes at least 30 days plus analysis time. This slows iteration to a crawl and makes it imperative to develop reliable lab tests that can serve as a proxy for real-world use.

Extending a wearable's wear time has two major benefits beyond convenience. It lowers costs by reducing device waste and the need for frequent healthcare worker assistance. More importantly, it dramatically increases patient compliance, as a once-a-month application is far easier to adhere to than a daily routine.

Unlike external machines, implanting parts internally triggers the body's powerful defenses. The immune system attacks foreign objects, and blood forms clots around non-native surfaces. These two biological responses are the biggest design hurdles for internal replacement parts, problems that external devices like dialysis machines don't face.

The technology's main constraints are reaching proteins outside the intracellular space (membrane-bound or secreted) and the limited chemical libraries explored so far. These are viewed as engineering challenges that will be overcome with time and new ligases, not as permanent roadblocks.

By continuously measuring a drug's effect on the body (pharmacodynamics), the wearable device provides a real-time view of a patient's phenotype. This granular data can revolutionize clinical trial design, safety monitoring, and drug dosing, moving beyond static genomic data to understand real-world drug response.

While wearables generate vast amounts of health data, the medical system lacks the evidence to interpret these signals accurately for healthy individuals. This creates a risk of false positives ('incidentalomas'), causing unnecessary anxiety and hindering adoption of proactive health tech.

Clinical trials often just report success rates and discard failed devices. This is a missed opportunity. By contractually requiring failed devices to be returned, R&D teams can analyze failure modes and create representative lab tests, drastically speeding up development and avoiding expensive repeat clinicals.

A device designed to track falls in dementia patients failed because the patients, confused about its purpose, simply took it off. This highlights a critical layer of usability beyond ergonomics: the device's function and presence must be comprehensible and non-threatening to the target patient's cognitive state.

A primary cause of wearable device failure is not major trauma, but frequent, minor impacts from daily life, such as brushing against a doorframe. Adding a thin, flexible overlay on top of the device absorbs these stresses, prevents edge lifting, and can increase the device's survival rate by four times.